Baxter International Aktie
35,95USD | 0,86USD | 2,44% |
WKN: 853815 / ISIN: US0718131099
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 50 000 | 60 000 | 60 000 | 60 000 | 38 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,23 | 0,21 | 0,25 | 0,25 | 0,28 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 8 411 | 8 872 | 8 011 | 9 600 | 8 853 |
Summe Anlagevermögen | 11 608 | 24 649 | 20 276 | 18 676 | 16 929 |
Summe Aktiva | 20 019 | 33 521 | 28 287 | 28 276 | 25 782 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 11 293 | 24 400 | 22 392 | 19 808 | 18 758 |
Summe Eigenkapital | 8 726 | 9 121 | 5 895 | 8 468 | 7 024 |
Summe Passiva | 20 019 | 33 521 | 28 287 | 28 276 | 25 782 |
Adresse
One Baxter Parkway, 60015-4625 Deerfield | |
Telefon | +1 (224) 948-2000 |
Internet | http://www.baxter.com |
Management
Alok Sonig
Executive VP & President-Pharmaceuticals |
Amy A. McBride-Wendell
Independent Director |
Angela B. Lee
Chief Diversity Officer |
Anita A. Zielinski
Chief Accounting Officer, Senior VP & Controller |
Caitlin Kelly
Manager-Finance Team |
Catherine R. Smith
Independent Director |
Cathy R Smith
Director |
Charles R. Patel
Chief Information Officer & Senior Vice President |
Clare Trachtman
Chief Investor Relations Officer & Senior VP |
D. Brent Shafer
Chairman & Chief Executive Officer |
Darren Evans
Vice President-Global Technical Services |
David S. Rosenbloom
Executive Vice President & General Counsel |
David S. Wilkes
Independent Director |
Ellen K. Bradford
Secretary & Senior Vice President |
Gerard Greco
Chief Quality Officer & Senior Vice President |
Heather Knight
Chief Operating Officer & Executive Vice President |
Heather Wechet
VP-Talent Management & Employee Relations |
James W. Borzi
Chief Supply Chain Officer & Executive VP |
Jeanne K. Mason
Chief Human Resources Officer & Executive VP |
Jeffrey A. Craig
Director |
Joel Todd Grade
Chief Financial Officer & Executive Vice President |
Karen L. Leets
Treasurer & Senior Vice President |
Lynn Pawelski
Vice President-Global Regulatory Affairs |
Nancy M. Schlichting
Lead Independent Director |
Nicolas Henry Roelofs
Development Manager |
Patricia B. Morrison
Independent Director |
Reaz Rasul
EVP, President-Healthcare Systems & Technologies |
Stacey T. Eisen
Chief Communications & Corporate Marketing Officer |
Stephen H. Rusckowski
Independent Director |
Stephen Newman Oesterle
Independent Director |
Tobi Karchmer
SVP, Chief Medical & Scientific Officer |
William A. Ampofo
Independent Director |